日本的静脉通路装置市场:各产品类型，各用途，各终端用户，各地区，机会，预测，2019年～2033年

日本血管通路设备市场规模预计将从 2025 年的 3.8844 亿美元增长到 2033 年的 5.8942 亿美元，预测期内（2026-2033 年）的复合年增长率为 6.14%。随着癌症和肾臟病等慢性疾病的发病率不断上升，推动了日本医疗保健环境中血管通路设备的使用增加，日本的血管通路设备市场正经历显着成长。政府的医疗改革和医院基础设施的改善进一步促进了先进血管技术的应用。此外，国内製造商对安全设计、抗感染导管的关注正在加速急性照护和长期照护环境中的市场成长。

例如，日本厚生劳动省于2024年12月1日批准了Clottriever DVT血栓切除系统的保险报销。此前，日本药品和医疗器材综合机构（PMDA）于2023年12月批准了Clottriever系统。厚生劳动省为Clottriever设立了新的功能类别，与以往基于导管的疗法不同，因为Clottriever的特殊作用机制使其能够彻底清除DVT患者动脉壁上的血栓。

本报告提供日本的静脉通路装置市场相关调查，提供市场概要，以及各产品类型，各用途，各终端用户，各地区趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 摘要整理

第4章 日本静脉通路装置市场预测，2019年～2033年

• 市场规模分析与预测
• 市场占有率分析与预测
• 2025年的市场地图分析
  • 各产品类型
  • 各用途
  • 各终端用户
  • 各地区

第5章 价值链分析

第6章 需求供给分析

第7章 进出口的分析

第8章 波特的五力分析

第9章 大环境分析

第10章 价格分析

第11章 市场动态

• 市场促进因素
• 市场课题

第12章 市场趋势与发展

第13章 法规结构和革新

第14章 竞争情形

• 前五名市场领导的竞争矩阵
• 前五名参与企业的SWOT分析
• 前10名市场主要企业的形势
  • Nippon Becton Dickinson Co Ltd
  • Teleflex Medical Japan Ltd
  • Nipro Medical Corporation
  • ICU Medical, Inc.
  • AngioDynamics, Inc.
  • Medtronic Japan Co. Ltd.
  • B. Braun Aesculap Japan Co., Ltd.
  • Terumo Corporation
  • Cook Medical Japan G.K.
  • Kawasumi Laboratories, Inc.

第15章 策略性建议

第16章 关于调查公司·免责声明

Japan vascular access devices market is projected to witness a CAGR of 6.14% during the forecast period FY2026-FY2033, growing from USD 388.44 million in FY2025 to USD 589.42 million in FY2033. Japan market for dermal fillers has grown significantly due to rising prevalence of chronic conditions such as cancer and renal disease is prompting increased use of vascular access devices across Japanese healthcare settings. Government healthcare reforms and hospital infrastructure upgrades are further facilitating the adoption of advanced vascular technologies. Additionally, local manufacturers' focus on safety-engineered, infection-resistant catheters is accelerating market growth in both acute and long-term care environments.

For example, the Japanese Ministry of Health, Labor and Welfare (MHLW) approved the ClotTriever Thrombectomy System for DVT for national reimbursement on December 1, 2024, according to a statement released today by Inari Medical, Inc., a medical device company dedicated to treating and improving the lives of patients with venous and other vascular diseases. This statement comes after the Pharmaceuticals and Medical Devices Agency (PMDA) approved the ClotTriever system in December 2023. MHLW established a new functional category distinct from previous catheter-based therapies because of ClotTriever's special mode of action for total, wall-to-wall thrombus elimination in patients with DVT.

Rising Geriatric Population and Prevalence of Chronic Conditions Driving Market Growth

Japan has one of the highest proportions of elderly individuals globally, with more than 29% of its population aged 65 or older. This aging demographic is more susceptible to chronic diseases such as cardiovascular disorders, diabetes, and cancer, which often require repeated intravenous treatments, thereby boosting the demand for vascular access devices. The increase in long-term hospital stays and the need for regular drug or fluid administration further propel the market. Additionally, age-related complications increase the likelihood of conditions like kidney failure, which often require dialysis through central vascular access. These factors collectively support the growing adoption of vascular access devices in Japan's healthcare system. For instance, according to Japan's Ministry of Internal Affairs and Communications, as of 2023, seniors (65+) made up 29.1% of the total population, highlighting the pressing need for chronic disease management solutions.

Technological Advancements and Focus on Infection Control in Hospitals Fueling Growth

Japanese healthcare facilities are placing greater emphasis on adopting technologically advanced vascular access devices that minimize infection risk and improve efficiency. Innovations in catheter coatings, antimicrobial materials, and securement devices have significantly reduced complications such as catheter-related bloodstream infections (CRBSIs). Japan's hospitals, known for their high standards of care and patient safety, are actively integrating smart vascular access technologies, such as ultrasound-guided placement and needle-free connectors, to enhance clinical outcomes. Moreover, post-pandemic hygiene awareness has accelerated the shift toward disposable and safer vascular access solutions. These trends are boosting the penetration of vascular access devices in both public and private healthcare settings. For example, in April 2024, Nipro partnered with Haselmeier to introduce the PiccoJect, a patient-centric autoinjector designed for 1 mL long and 2.25 mL, pre-filled syringes. The device was showcased at CPHI Japan in Tokyo, which marks Nipro's commitment to innovative drug delivery solutions.

Increasing Demand for Peripheral Vascular Access Devices for Short-Term Use

Peripheral vascular access devices are witnessing a significant rise in adoption across Japan due to their widespread use in short-term therapies such as drug infusions, fluid administration, and nutritional support. These devices, including peripheral intravenous (PIV) catheters, are easy to insert, cost-effective, and less invasive compared to central vascular access devices, making them ideal for outpatient departments, emergency care, and routine medical interventions. The increasing number of outpatient surgeries, homecare treatments, and emergency admissions in Japan's aging healthcare infrastructure is supporting the demand for these products. Additionally, patient preference for minimally invasive and shorter treatment durations aligns with the utility of peripheral devices. Healthcare providers in Japan are also investing in newer-generation safety-engineered PIV catheters that minimize needlestick injuries and infection risks, enhancing procedural outcomes and staff safety. These developments are collectively contributing to the growing adoption of peripheral vascular access devices in Japan's evolving clinical care landscape. In March 2024, B. Braun Aesculap Japan introduced "Introcan Safety(R) 2 IV Catheter," which features enhanced safety mechanisms to reduce needlestick injuries and is tailored for peripheral access in short-term treatments.

Future Market Scenario (FY2026 - FY2033F)

The Japan vascular access devices market is poised for steady growth in the coming years, driven by an aging population, rising chronic disease burden, and an evolving healthcare system that emphasizes minimally invasive treatments. As hospitals and clinics increasingly adopt advanced vascular access technologies to reduce infection risks and improve patient outcomes, demand for both central and peripheral access devices is expected to rise. The market is also likely to benefit from local innovation, government support for digital healthcare, and a growing preference for home-based care. Continuous R&D and product upgrades will further enhance market penetration across urban and rural settings.

Key Players Landscape and Outlook

Key players in the vascular access devices industry utilize strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, In January 2025, Nipro announced the international sales launch of the DIAMAX WOW Single Patient Dialysis Machines. This product introduction shows Nipro's dedication for advancing the dialysis technology and improving patient care.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Japan Vascular Access Devices Market Outlook, FY2019-FY2033F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. Central Vascular Access Device
    • 4.2.1.2. Peripheral Vascular Access Device
    • 4.2.1.3. Accessories
  • 4.2.2. By Application
    • 4.2.2.1. Drug Administration
    • 4.2.2.2. Fluid and Nutrition Administration
    • 4.2.2.3. Blood Transfusion
    • 4.2.2.4. Diagnostics
  • 4.2.3. By End-user
    • 4.2.3.1. Hospitals
    • 4.2.3.2. Clinics
    • 4.2.3.3. Ambulatory Surgical Centers
    • 4.2.3.4. Others
  • 4.2.4. By Region
    • 4.2.4.1. North [Hokkaido and Tohoku]
    • 4.2.4.2. Central [Kanto and Chubu]
    • 4.2.4.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa]
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2025)
• 4.3. Market Map Analysis, FY2025
  • 4.3.1. By Product Type
  • 4.3.2. By Application
  • 4.3.3. By End-user
  • 4.3.4. By Region

5. Value Chain Analysis

6. Demand Supply Analysis

7. Import and Export Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

14. Competitive Landscape

• 14.1. Competition Matrix of Top 5 Market Leaders
• 14.2. SWOT Analysis for Top 5 Players
• 14.3. Key Players Landscape for Top 10 Market Players
  • 14.3.1. Nippon Becton Dickinson Co Ltd
    • 14.3.1.1. Company Details
    • 14.3.1.2. Key Management Personnel
    • 14.3.1.3. Products and Services
    • 14.3.1.4. Financials (As Reported)
    • 14.3.1.5. Key Market Focus and Geographical Presence
    • 14.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 14.3.2. Teleflex Medical Japan Ltd
  • 14.3.3. Nipro Medical Corporation
  • 14.3.4. ICU Medical, Inc.
  • 14.3.5. AngioDynamics, Inc.
  • 14.3.6. Medtronic Japan Co. Ltd.
  • 14.3.7. B. Braun Aesculap Japan Co., Ltd.
  • 14.3.8. Terumo Corporation
  • 14.3.9. Cook Medical Japan G.K.
  • 14.3.10. Kawasumi Laboratories, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Japan Vascular Access Devices Market, By Value, In USD Million, FY2019-FY2033F
• Figure 2. Japan Vascular Access Devices Market, By Volume, In Million Units, FY2019-FY2033F
• Figure 3. Japan Vascular Access Devices Market Share (%), By Product Type, FY2019-FY2033F
• Figure 4. Japan Vascular Access Devices Market Share (%), By Application, FY2019-FY2033F
• Figure 5. Japan Vascular Access Devices Market Share (%), By End-user, FY2019-FY2033F
• Figure 6. Japan Vascular Access Devices Market Share (%), By Region, FY2019-FY2033F
• Figure 7. By Product Type Map-Market Size (USD Million) & Growth Rate (%), FY2025
• Figure 8. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2025
• Figure 9. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2025
• Figure 10. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2025